JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Keith S. Naunheim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naunheim, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naunheim, K. S.
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2007;133:1412-1413
© 2007 The American Association for Thoracic Surgery

Editorial

Lung-volume reduction surgery: A vanishing operation?

Keith S. Naunheim, MD*

Department of Thoracic Surgery, St Louis University, St Louis, Mo.

Received for publication January 19, 2007; accepted for publication January 31, 2007.

* Address for reprints: Keith S. Naunheim, MD, Thoracic Surgery, St Louis University, 3635 Vista Ave at Grand Blvd, St Louis, MO 63110.

The first 20% of the full text of this article appears below.

GoThe article by Lederer and colleagues1Go in this issue of the Journal reports on a small series of patients with end-stage emphysema undergoing lung-volume reduction surgery (LVRS) with good clinical results and amazingly low morbidity and mortality. The purpose of the article is to correlate improvements in clinical status with the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index, a multidimensional predictor of survival in patients with chronic obstructive pulmonary disease. The authors suggest that the BODE index may eventually prove useful as a surrogate to predict survival not only for patients with chronic obstructive pulmonary disease, but for those with end-stage emphysema undergoing LVRS. Their conclusions regarding the BODE index, however, must be regarded with caution because of a number of inherent limitations in their study. First, as the authors themselves point out, the study includes a small number of patients operated . . . [Full Text of this Article]


Related Article

Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year
David J. Lederer, Byron M. Thomashow, Mark E. Ginsburg, John H.M. Austin, Matthew N. Bartels, Chun K. Yip, Patricia A. Jellen, Frances L. Brogan, Steven M. Kawut, Roger A. Maxfield, Angela M. DiMango, Paul F. Simonelli, Lyall A. Gorenstein, Gregory D.N. Pearson, and Joshua R. Sonett
J. Thorac. Cardiovasc. Surg. 2007 133: 1434-1438. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.